The association between HIV diagnosis disclosure and adherence to anti-retroviral therapy among adolescents living with HIV in Sub-Saharan Africa: A systematic review and meta-analysis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 09 12 2021
accepted: 26 04 2023
medline: 15 5 2023
pubmed: 11 5 2023
entrez: 11 5 2023
Statut: epublish

Résumé

Nine in ten of the world's 1.74 million adolescents living with human immunodeficiency virus (ALHIV) live in Sub-Saharan Africa. Suboptimal adherence to antiretroviral therapy (ART) and poor viral suppression are important problems among adolescents. To guide intervention efforts in this regard, this review presented pooled estimates on the prevalence of adherence and how it is affected by disclosure of HIV status among ALHIV in Sub-Saharan Africa. A comprehensive search in major databases (Excerpta Medica database (EMBASE), PubMed, Ovid/MEDLINE, HINARI, and Google Scholar) with additional hand searches for grey literature was conducted to locate observational epidemiologic studies published in English up to November 12, 2022 with the following inclusion criteria: primary studies that reported disclosure of HIV status as an exposure variable, had positive adherence to ART as an outcome, and conducted among adolescents and children. The COVIDENCE software was used for a title/abstract screening, full-text screening, the JBI quality assessment checklist, and data extraction. Random effects model was used to pool estimates. Furthermore, sensitivity analysis and subgroup analysis were also conducted by age groups and type of adherence measures used. This meta-analysis combines the effect estimates from 12 primary studies with 4422 participants. The prevalence of good adherence to ART was 73% (95% CI (confidence interval): 56 to 87; I2 = 98.63%, P = <0.001), and it was higher among adolescents who were aware of their HIV status, 77% (95% CI: 56 to 92; I2 = 98.34%, P = <0.001). Overall, knowledge of HIV status was associated with increased odds of adherence (odds ratio (OR) = 1.88, 95% CI: 1.21 to 2.94; I2 = 79.8%, P = <0.001). This was further supported in a subgroup analysis by age (seven studies, pooled OR = 1.89, 95% CI: 1.06 to 3.37; I2 = 81.3%, P = <0.0001) and whether primary studies controlled for confounding factors (six studies provided adjusted estimates, pooled OR = 2.61, 95% CI: 1.22 to 5.57; I2 = 88.1%, P = <0.001) confirmed this further. Our meta-analysis and systematic review revealed that knowledge of one's HIV status was associated with adherence to ART, particularly among adolescents. The findings underscored the importance of encouraging disclosure in order to enhance adherence among adolescents.

Identifiants

pubmed: 37167342
doi: 10.1371/journal.pone.0285571
pii: PONE-D-21-36858
pmc: PMC10174542
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0285571

Informations de copyright

Copyright: © 2023 Mengesha et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Circulation. 2017 Sep 5;136(10):e172-e194
pubmed: 28784624
Public Health. 2018 Apr;157:20-31
pubmed: 29501984
PLoS Med. 2007 Oct 16;4(10):e298
pubmed: 17941716
AIDS. 2015 Jun;29 Suppl 1:S57-65
pubmed: 26049539
Medicina (Kaunas). 2019 Aug 02;55(8):
pubmed: 31382540
AIDS Care. 2016 Jul;28(7):825-33
pubmed: 26837437
Patient Prefer Adherence. 2016 Mar 15;10:329-37
pubmed: 27042024
J Int AIDS Soc. 2014 Mar 10;17:18866
pubmed: 24629845
Pediatrics. 1999 Jan;103(1):164-6
pubmed: 9917458
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
AIDS Patient Care STDS. 2015 May;29(5):248-66
pubmed: 25825938
BMJ Open. 2018 Aug 30;8(8):e019554
pubmed: 30166287
AIDS Care. 2015;27(7):805-16
pubmed: 25702789
PLoS One. 2012;7(12):e52856
pubmed: 23285204
Lancet HIV. 2021 Jun;8(6):e353-e362
pubmed: 33932330
J Paediatr Child Health. 2018 Jul;54(7):728-734
pubmed: 29436053
J Int Assoc Provid AIDS Care. 2015 Mar-Apr;14(2):156-62
pubmed: 25421930
J Int AIDS Soc. 2016 Apr 27;19(1):20683
pubmed: 27125320
J Dev Behav Pediatr. 2007 Apr;28(2):155-66
pubmed: 17435473
BMC Pediatr. 2013 Sep 02;13:132
pubmed: 24229394
Syst Rev. 2020 Jul 14;9(1):160
pubmed: 32665026
Afr J AIDS Res. 2006 May;5(1):17-26
pubmed: 25875143
Curr HIV/AIDS Rep. 2013 Jun;10(2):159-68
pubmed: 23563990
J Acquir Immune Defic Syndr. 2009 May 1;51(1):65-71
pubmed: 19282780
AIDS Care. 2014;26(9):1144-9
pubmed: 24625136
AIDS. 2012 Jun 19;26(10):1231-41
pubmed: 22706009
J Int AIDS Soc. 2013 May 27;16:18466
pubmed: 23714198
AIDS. 2014 Aug 24;28(13):1945-56
pubmed: 24845154
AIDS Behav. 2011 Aug;15(6):1121-7
pubmed: 20607381
J Int AIDS Soc. 2017 May 16;20(Suppl 3):21520
pubmed: 28530036
BMC Public Health. 2014 Aug 26;14:875
pubmed: 25155293
Res Synth Methods. 2010 Apr;1(2):97-111
pubmed: 26061376
J Clin Ethics. 2008 Spring;19(1):31-42
pubmed: 18552051
AIDS Behav. 2017 Jan;21(1):59-69
pubmed: 27395433
PLoS One. 2017 Oct 9;12(10):e0183180
pubmed: 28991913
Arch Public Health. 2014 Nov 10;72(1):39
pubmed: 25810908
BMC Pediatr. 2022 Nov 10;22(1):653
pubmed: 36357856
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
BMC Public Health. 2014 Apr 15;14:365
pubmed: 24735561
Afr J AIDS Res. 2022 Oct;21(3):251-260
pubmed: 36111384
BMC Public Health. 2021 Dec 13;21(1):2274
pubmed: 34903209
Lancet Glob Health. 2020 Feb;8(2):e167-e168
pubmed: 31924538
AIDS. 2015 Feb 20;29(4):493-502
pubmed: 25565496
Ann Trop Paediatr. 2007 Jun;27(2):123-31
pubmed: 17565809
J Trop Pediatr. 2010 Dec;56(6):440-2
pubmed: 20185559
J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S103-6
pubmed: 12562030
J Acquir Immune Defic Syndr. 2015 May 1;69(1):98-108
pubmed: 25942461
J Acquir Immune Defic Syndr. 2014 Jul 1;66 Suppl 2:S144-53
pubmed: 24918590
AIDS Care. 2008 Aug;20(7):842-52
pubmed: 18608054
Ann Pharmacother. 2011 Mar;45(3):372-9
pubmed: 21386024
Ann Intern Med. 2000 Jul 4;133(1):21-30
pubmed: 10877736
J Int AIDS Soc. 2022 May;25(5):e25910
pubmed: 35543100
AIDS. 2014 Feb 20;28(4):559-68
pubmed: 24076661
AIDS. 2000 Mar 10;14(4):357-66
pubmed: 10770537
Pediatr Infect Dis J. 2008 Aug;27(8):686-91
pubmed: 18574439
BMC Med Res Methodol. 2020 Jan 13;20(1):7
pubmed: 31931747
Trials. 2017 Dec 14;18(1):595
pubmed: 29237487

Auteurs

Melkamu Merid Mengesha (MM)

School of Public Health, College of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia.

Awugchew Teshome (A)

School of Public Health, College of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia.

Dessalegn Ajema (D)

School of Public Health, College of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia.

Abera Kenay Tura (AK)

School of Nursing and Midwifery, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.

Inger Kristensson Hallström (IK)

Faculty of Medicine, Department of Health Sciences, Child and Family Health, Lund University, Lund, Sweden.

Degu Jerene (D)

Faculty of Medicine, Department of Health Sciences, Child and Family Health, Lund University, Lund, Sweden.
KNCV Tuberculosis Foundation, Hague, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH